MATTHEW SHARPE: Open Payments
NPI 1407052061 · PENFIELD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,179 in 48 payments from 8 companies in 2025. Trend: 2023 $15,428 · 2024 $15,748 · 2025 $11,179
Speaker / faculty: $8,460Travel & lodging: $1,451Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 19 | $10,566 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $199 |
| Teva Pharmaceuticals USA, Inc. | 13 | $138 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| Lundbeck LLC | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Corium, LLC | 1 | $14 |
Products named: SPRAVATO, CAPLYTA, REXULTI, AUSTEDO XR, TRINTELLIX, Qelbree, Azstarys.
Industry payments across NY — which companies pay providers there.
